Poxton IR, Bell GT, Barclay GR (1985): The association on SDS-polyacrylamide gels of lipopolysaccharide and outer membrane proteins of Pseudomonas aeruginosa as revealed by monoclonal antibodies and Western blotting. FEMS Microbiol Letts 27:247-251.
Barclay GR, Yap PL, McClelland DBL, Jones RJ, Roe EA, McCann MC, Micklem LR, James K (1986): Characterization of mouse monoclonal antibodies produced by immunization with a single serotype component of a polyvalent Pseudomonas aeruginosa vaccine. J Med Microbiol 21:87-90.
Barclay GR, Scott BB (1987): Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme- linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies. Infect Immun 55:2706-2714.
Scott BB, Barclay GR (1987): Endotoxin-polymyxin complexes in an improved enzyme-linked immunosorbent assay for IgG antibodies in blood donor sera to Gram-negative endotoxin core glycolipid. Vox Sang 52:272-280.
Barclay GR, Scott BB, Wright IH, Rogers PN, Smith DG, Poxton IR (1989): Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock. Circ Shock 29:93-106.
Barclay GR (1990): Antibodies to endotoxin in health and disease. Rev Med Microbiol 1:133-142.
Nelson JW, Barclay GR, Govan JRW (1990): Pseudomonas aeruginosa flagellar antibodies in serum, saliva and sputum from patients with cystic fibrosis. Serodiag Immunother 4:351-361.
Nelson JW, Barclay GR, Govan JRW (1990): Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by ELISA for anti-Pseudomonas LPS IgG antibodies. Serodiag Immunother 4:9-16.
Scott BB, Barclay GR (1990): IgG antibodies to Gram-negative endotoxin in human sera. II. Opsonic activity of cross reactive antibodies to endotoxin core for rough and smooth bacteria. Serodiag Immunother 4:39-51.
Scott BB, Barclay GR, Smith DGE, McLoughlin F, Poxton IR (1990): IgG antibodies to Gram-negative endotoxin in human sera. I. Lipopolysaccharide (LPS) cross-reactivity due to antibodies to LPS core. Serodiag Immunother 4:25-38.
Di Padova FE, Barclay GR, Liehl E (1991): Identification of widely cross-reactive and cross-protective anti-LPS core monoclonal antibodies (MAbs). Circ Shock 34:118-119.
Gardiner KR, Barclay GR, McCaigue MD, Erwin PJ, Stephens S, Halliday MI, Maxwell RJ, Rowlands BJ (1991): Endotoxin, tumour necrosis factor and anti-core glycolipid antibodies in inflammatory bowel disease. Br J Surg 78:1488.
Gibb AP, Barclay GR, Poxton IR, Di Padova F (1992): Frequencies of lipopolysaccharide core types among clinical isolates of Escherichia coli defined with monoclonal antibodies. J Infect Dis 166:1051-1057.
Gram H, Di Padova FE, Barclay GR, Poxton IR (1992): Monoclonal antibody against LPS core. International Patent Application No PCT/EP92/00380. PCT Int Publ No WO 92/16624 1 October.
Nelson JW, Barclay GR, Micklem LR, Poxton IR, Govan JR (1992): Production and characterisation of mouse monoclonal antibodies reactive with the lipopolysaccharide core of Pseudomonas aeruginosa. J Med Microbiol 36:358-365.
Reidy J, Wright I, Boom SJ, Barclay R, Di Padova F, Ramsay G (1992): Prevention of cardiovascular effects of endotoxaemia by monoclonal antibodies specific for core endotoxin. Br J Surg 79:1087-1090.
Clements WDB, Halliday MI, McCaigue MD, Barclay GR, Rowlands BJ (1993): Effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity. Arch Surg 128:200-205.
Curley PJ, McMahon MJ, Lancaster F, Banks RE, Barclay GR, Shefta J, Boylston AW, Whicher JT (1993): Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity. Br J Surg 80:1312-1315.
Di Padova FE, Brade H, Barclay GR, Poxton IR, Liehl E, Schuetze E, Kocher HP, Ramsay G, Schreier MH, McClelland DBL, Rietschel ET (1993): A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharide. Infect Immun 61:3863-3872.
Mythen MG, Barclay GR, Purdy G, Hamilton-Davies C, Mackie IJ, Webb AR, Machin SJ (1993): The role of endotoxin immunity, neutrophil degranulation and contact activation in the pathogenesis of post-operative organ dysfunction. Blood Coagul Fibrinolysis 4:999-1005.
Windsor JA, Fearon KC, Ross JA, Barclay GR, Smyth E, Poxton I, Garden OJ, Carter DC (1993): Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg 80:1042-1046.
Di Padova FE, Mikol V, Barclay GR, Poxton IR, Brade H, Rietschel ET (1994): Anti-lipopolysaccharide core antibodies. Prog Clin Biol Res 388:85-94.
Gardiner KR, Halliday MI, Barclay GR, McCaigue MD, Erwin PJ, Milne L, Stephens S, Maxwell RJ, Rowlands BJ (1994): The significance of systemic endotoxaemia in inflammatory bowel disease. Gut 36:897-901.
Heyderman RS, Fitzpatrick MM, Barclay GR (1994): Haemolytic-uraemic syndrome [letter]. Lancet 343:1042.
Kennedy JA, Kirk SJ, McCrory DC, Halliday MI, Barclay GR, Rowlands BJ (1994): Modulation of immune function and weight loss by L- arginine in obstructive jaundice in the rat. Br J Surg 81:1199-1201.
Refsum SE, McCaigue M, Campbell GR, Barclay GR, Erwin PJ, Rowlands BJ, Boston VE, Halliday MI (1994): Pentoxifylline modulates cytokine responses in a sepsis model. Prog Clin Biol Res 388:323-333.
Allan E, Poxton IR, Barclay GR (1995): Anti-bacteroides lipopolysaccharide IgG levels in healthy adults and sepsis patients. FEMS Immunol Med Microbiol 11:5-12.
Delahooke DM, Barclay GR, Poxton IR (1995): A re-appraisal of the biological activity of bacteroides LPS. J Med Microbiol 42:102-112.
Delahooke DM, Barclay GR, Poxton IR (1995): Tumor necrosis factor induction by an aqueous phenol- extracted lipopolysaccharide complex from Bacteroides species. Infect Immun 63:840-846.
Gardiner KR, Maxwell RJ, Rowlands BJ, Barclay GR (1995): Intestinal permeability [letter]. Gut 37:589.
Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S, Maxwell RJ, Rowlands BJ (1995): Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 36:897-901.
Goldie AS, Fearon KCH, Ross JA, Barclay GR, Jackson RE, Grant IS, Ramsay G, Blyth AS, Howie JC (1995): Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. JAMA 274:172-177.
Hodgson JC, Barclay GR, Hay LA, Moon GM, Poxton IR (1995): Prophylactic use of human endotoxin-core hyperimmune gammaglobulin to prevent endotoxaemia in colostrum- deprived, gnotobiotic lambs challenged orally with Escherichia coli. FEMS Immunol Med Microbiol 11:171-180.
Anderson K, McSharry CP, Clark C, Clark CJ, Barclay GR, Morris GP (1996): Sump bay fever: inhalational fever associated with a biologically contaminated water aerosol. Occup Environ Med 53:106-111.
Hamilton-Davies C, Barclay GR, Murphy WG, Machin SJ, Webb AR (1996): Passive immunisation with IgG endotoxin core antibody hyperimmune fresh frozen plasma. Vox Sang 71:165-169.
Bennett-Guerrero E, Ayuso L, Hamilton-Davies C, White WD, Barclay GR, Smith PK, King SA, Muhlbaier LH, Newman MF, Mythen MG (1997): Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 277:646-650.
Pentreath VW, Alafiatayo RA, Barclay GR, Crawley B, Doua F, Oppenheim BA.(1997): Endotoxin antibodies in African sleeping sickness. Parasitology 114:361-365.)
Reynolds JV, Kanwar S, Welsh FK, Windsor AC, Murchan P, Barclay GR, Guillou PJ.(1997): 1997 Harry M. Vars Research Award. Does the route of feeding modify gut barrier function and clinical outcome in patients after major upper gastrointestinal surgery? JPEN J Parenter Enteral Nutr 21:196-201.
Soong CV, Halliday MI, Barclay GR, Hood JM, Rowlands BJ, Barros D'Sa AAB.(1997): Intramucosal acidosis and systemic host responses in abdominal aortic aneurysm surgery. Crit Care Med 25:1472-1479.
Hughes JE, Stewart J, Barclay GR, Govan JR.(1997): Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun 65:4281-4287.
Clements WD, Erwin P, McCaigue MD, Halliday I, Barclay GR, Rowlands BJ.(1998): Conclusive evidence of endotoxaemia in biliary obstruction. Gut 42:293-299.
Gabe SM, Bjarnason I, Tolou-Ghamari Z, Tredger JM, Johnson PG, Barclay GR, Williams R, Silk DB.(1998): The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology 115:67-74.
Wakefield CH, Barclay GR, Fearon KC, Goldie AS, Ross JA, Grant IS, Ramsay G, Howie JC.(1998): Proinflammatory mediator activity, endogenous antagonists and the systemic inflammatory response in intra-abdominal sepsis. Scottish Sepsis Intervention Group. Br J Surg 85:818-825.
Welsh FK, Farmery SM, MacLennan K, Sheridan MB, Barclay GR, Guillou PJ, Reynolds JV.(1998): Gut barrier function in malnourished patients. Gut 42:396-401.
Welsh FK, Ramsden CW, MacLennan K, Sheridan MB, Barclay GR, Guillou PJ, Reynolds JV.(1998): Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice. Ann Surg 227:205-212.
Cross AS, Opal SM, Bhattacharjee AK, Barclay GR, Palardy JE, Buffum K, Parejo N (1999): Active immunization with a detoxified Escherichia coli J5 lopopolysaccharide-group B meningococcal outer membrane protein complex vaccine protects immunocompromised animals from experimental Klebsiella and Pseudomonas sepsis. (submitted: J Clin Infect)
Barclay GR. (1999): Endotoxin-core antibodies: time for a reappraisal? (editorial) Int Care Med (in press)
Barclay GR, Yap PL, McClelland DBL, McCann MC, Micklem LR, James K, Poxton IR, Jones RJ, Roe EA (1984): Monoclonal antibodies to pseudomonas aeruginosa following immunizations with antigens from two different pseudomonas serotypes: specificity and protection. International Symposium on Monoclonal Antibodies (Florence) Abstract Volume:112. (Abstract)
Barclay GR, Poxton IR, Scott BB, McClelland DBL (1985): Gram-negative bacterial antibodies in blood donors. Brit Soc for study of Infection (Abstract)
Barclay GR, Scott BB, Smith DGE, Poxton IR (1986): Antibodies to Gram-negative LPS core-glycolipid in a naturally-immune blood donor population: potential for hyperimmune IgG production. 4th Int Symp on Infection in the Immunocompromised Host (Abstract)
Smith DGE, Scott BB, Barclay GR, Poxton IR (1987): Antibodies to lipopolysaccharides in blood donor serum. 3rd European Congress in Clinical Microbiology (Abstract)
Barclay GR, Scott BB, Milne L, Smith DGE, Poxton IR, Wright IH, Rogers PN (1988): Quantitative and qualitative analysis of IgG antibodies to endotoxin core-glycolipids in healthy adults and shock patients: prospects for passive immunotherapy. International Symposium on Endotoxin (International Endotoxin Society) (Abstract)
Scott BB, Barclay GR, Smith DGE, Poxton IR (1988): Detailed analysis of anti-endotoxin core glycolipid antibodies present in IgG from selected human sera. International Symposium on Endotoxin (International Endotoxin Society) (Abstract)
Barclay GR, Scott BB, McMillan LA, McLoughlin F, Smith DGE, Poxton IR (1989): Anti-endotoxin antibody responses in rabbits immunized sequentially with different rough and smooth Gram-negative bacteria. 4th European Congress in Clinical Microbiology (Abstract)
Barclay GR, Scott BB, Smith DGE, McLoughlin F, Poxton IR, McCartney AC, Wright IH (1989): Endotoxaemia and changes in circulating anti-endotoxin antibodies in longitudinal studies of septic shock cases. 4th European Congress in Clinical Microbiology (Abstract)
Barclay GR (1989): Strategies for passive immunotherapy of Gram-negative bacterial septicaemia: options for acquiring suitable antibodies. Brit Soc Blood Transf annual meeting (Abstract)
Poxton IR, Bathgate AJ, McLoughlin F, McMillan LA, Scott BB, Barclay GR (1989): Binding of anti-lipid A, anti-core and anti-O-antigen monoclonal antibodies to whole bacteria and isolated lipopolysaccharide. 4th European Congress in Clinical Microbiology (Abstract)
Barclay GR, Scott BB (1990): Ubiquitous cross-reactive anti-endotoxin core IgG antibodies in human sera are opsonic for smooth Gram-negative pathogens. 1st Congress of the International Endotoxin Society (Abstract)
Barclay GR, Scott BB, Poxton IR, McLoughlin F, McMillan LA, Di Padova FE, Schreier MH (1990): Monoclonal antibodies to endotoxin core: specificity, cross-reactivity and serology. 1st Congress of the International Endotoxin Society (Abstract)
Barclay GR (1990): Anti-endotoxin-core antibodies and endotoxaemia. Symp on Clinical Endotoxin Testing,Warwick (Abstract)
Di Padova FE, Barclay GR, Kocher HP, Poxton IR, Schreier MH (1990): Monoclonal antibodies to endotoxin core are able to block LPS-induced Il-1 and Il-6 release by murine peritoneal macrophages. 1st Congress of the International Endotoxin Society (Abstract)
Nelson JW, Govan JRW, Barclay GR, Micklem LR, James K (1990): Development of a sandwich ELISA for the early detection od Pseudomonas aeruginosa colonization in patients with CF. Paediatr Pulmonol 5 Suppl:274-275. (Abstract)
Reidy J, Wright IH, Runcie C, Smith H, Ramsay G, Barclay GR, Di Padova FE, Huber-Wegman G (1990): Protective effect of monoclonal antibodies (MAb) specific for LPS core in experimental endotoxic shock. 1st Congress of the International Endotoxin Society (Abstract)
Barclay GR (1991): Prevalence of anti-endotoxin-core antibodies in different clinical conditions associated with endotoxaemia and sepsis. IBC Conference: New Advances in the Treatment of Endotoxaemia and Sepsis (Abstract)
Barclay GR (1991): Pharmacokinetics of human anti-endotoxin-core antibodies from hyperimmune intravenous gammaglobulin following administration to animals and to patients with or without endotoxaemia. IBC Conference: New Advances in the Treatment of Endotoxaemia and Sepsis (Abstract)
Di Padova FE, Kocher HP, Barclay GR, Gram H, Schreier MH (1991): Anti-core LPS MAbs block LPS induced cytokine release by murine peritoneal macrophages. J Cell Biochem Suppl 15E:132. (Abstract)
Gram H, Tees R, Barclay GR, Di Padova FE (1991): The isotype of an anti-core LPS MAb as a determinant of lipid A reactivity. J Cell Biochem S 15E:118. (Abstract)
Nelson JW, Govan JRW, Barclay GR, Micklem LR, James K (1991): Development of a sandwich ELISA for the early detection of Pseudomonas aeruginosa colonization in patients with CF. Cystic Fibrosis Research Trust: Research Workers' Conference,Warwick (Abstract)
Barclay GR, McColm J (1992): Endotoxin core antibody (EndoCAb) levels in healthy adults and in various clinical conditions associated with endotoxaemia. 2nd Congress of the International Endotoxin Society (Abstract)
Barclay GR, McColm J, Poxton IR, Edmond DM, Di Padova FE (1992): Inhibition of laboratory and clinical (plasma) endotoxin LAL activity by an anti-core monoclonal antibody. 2nd Congress of the International Endotoxin Society (Abstract)
Barclay GR, McColm J (1992): Endotoxaemia and anti-endotoxin-core antibodies. Symp on Clinical Endotoxin Testing,Warwick (Abstract)
Clements WDB, McCaigue MD, Erwin PJ, Halliday MI, Barclay GR, Rowlands BJ (1992): The effect of obstructive jaundice on Kupffer cell clearance capacity (KCCC). Eur Surg Res 24 S2:113-114. (Abstract)
Di Padova FE, Gram H, Barclay GR, Liehl E, Rietschel ET (1992): SDZ 219-800 a broadly cross-neutralizing anti-E.coli LPS antibody. Int Care Med 18 S2:S107. (Abstract)
Di Padova FE, Barclay GR, Liehl E (1992): Widely crossreactive anti-LPS core monoclonal antibodies have LPS neutralizing properties. J Cell Biochem Suppl 16C:Abs CB 404. (Abstract)
Donnelly S, Zamani A, Barclay GR, Pollock A, Steedman D, Robertson C, Haslett C (1992): Endotoxin, antiendotoxin core antibodies, and oxygen requirement after multiple trauma. Thorax 47:245P. (Abstract)
Gardiner KR, Barclay GR, McMillan SA, Halliday MI, Rowlands BJ (1992): Differentiation of ulcerative colitis (UC) from Crohn's disease (CD). Gastroenterol 102:A626. (Abstract)
McColm J, Barclay GR (1992): Inhibition of endotoxin LAL activity by monoclonal antibody. Symp on Clinical Endotoxin Testing,Warwick (Abstract)
McCrory DC, Halliday MI, Barclay GR, McCaigue MD, Erwin PJ, Stephens S, Rowlands BJ (1992): The importance of anti-endotoxin antibodies in patients with obstructive jaundice. HPB Surg 5 S:5. (Abstract)
McCrory DC, Halliday MI, McCaigue MD, Barclay GR, Rowlands BJ (1992): Pre-operative rise and post-operative consumption of anti-endotoxin antibodies in jaundiced patients. Br J Surg 79:1237. (Abstract)
McCrory DC, Halliday MI, Barclay GR, McCaigue MD, Stephens S, Rowlands BJ (1992): Consumption of antiendotoxin antibodies in patients with obstructive jaundice. Surg Infect Soc (Abstract)
Mythen MG, Barclay GR, Browne D, Machin SJ, Webb AR (1992): Endogenous anti-endotoxin-core antibodies, gut mucosal perfusion and post operative multiple organ dysfunction syndrome. Int Care Med 18:S57. (Abstract)
Nelson JW, Butler SL, Brown PH, McColm J, Barclay GR, Govan JRW (1992): Detection and nature of the antibody response to Pseudomonas cepacia in patients with cystic fibrosis. 11th International Cystic Fibrosis Congress (Abstract)
Barclay GR (1993): Endotoxin and endotoxin-core antibodies (EndoCAb) in sepsis. J Med Microbiol 39:S1;P327. (Abstract)
Barclay GR (1993): The endotoxin-core antibody (EndoCAb) ELISA: an aid in assessment of endotoxaemia and sepsis? ICEA IV Abstracts & Programme 35. (Abstract)
Boom SJ, Davidson JAH, Reidy J, Di Padova FE, Barclay GR, Poxton IR, Ramsay G (1993): Abolition of the hyperdynamic cardiovascular state induced by endotoxaemia with a murine IgG monoclonal antibody to endotoxin. Surg Infect Soc Europe meeting (Abstract)
Clements WDB, Erwin PJ, Halliday MI, Barclay GR, Rowlands BJ (1993): Extrahepatic biliary obstruction promotes bacterial translocation. Soc for Surgery of the Alimentary Tract (Boston)USA p113. (Abstract)
Clements WDB, Halliday MI, Erwin PJ, McCaigue MD, Barclay GR, Rowlands BJ (1993): Conclusive evidence for endotoxaemia in biliary obstruction. Gut 34 S56:F223. (Abstract)
Clements WDB, Erwin PJ, Barclay GR, Halliday MI, Rowlands BJ (1993): Sensitivity and specificity of the EndoCAb assay assessed in biliary obstruction. ICEA IV Abstracts & Programme 35. (Abstract)
Clements WDB, Halliday MI, Irwin P, McCaigue MD, Barclay GR, Rowlands BJ (1993): Decreased Kupfer cell clearance capacity (KCCC) contributes to endotoxaemia seen in obstructive jaundice. Irish J Med Sci 162:234. (Abstract)
Clements WDB, Erwin PJ, McCaigue MD, Barclay GR, Barr J, Anderson NH, Halliday MI, Rowlands BJ (1993): The role of the gut-liver axis in obstructive jaundice. ICEA IV Abstracts & Programme 44. (Abstract)
Clements WDB, Campbell GR, Halliday MI, Barclay GR, Rowlands BJ (1993): The effect of obstructive jaundice on systemic concentrations of bile acids, histamine and antibodies to the core region of endotoxin glycolipid. Agents Actions 38:C283-C285. (Abstract)
Clements WDB, Halliday MI, Barclay GR, Rowlands BJ (1993): Biliary decompression restores Kupfer cell function in obstructive jaundice. Gut 34 S8:W29. (Abstract)
Clements WDB, Erwin PJ, Halliday MI, Barclay GR, Rowlands BJ (1993): The effects of extrahepatic obstructive jaundice on Kupfer cell function and gut mucosal integrity in relation to systemic endotoxaemia. J Irish Coll Phys Surg 22:228-229. (Abstract)
Clements WDB, McCrory DC, Barclay GR, Erwin PJ, Halliday MI, Rowlands BJ (1993): Conclusive evidence for endotoxaemia in biliary obstruction. ICEA IV Abstracts & Programme 30. (Abstract)
Davidson JAH, Boom SJ, Barclay GR, Ramsay G (1993): Plasma endotoxin levels in the 48 hour period following administration of HA-1A (Centoxin). Medicina Intensiva 17 S1:150. (Abstract)
Di Padova FE, Brade H, Barclay GR, Poxton IR, Liehl E, Rietschel ET (1993): Anti-LPS immunotherapy: a broadly cross-protective monoclonal antibody (MAb) binding to E.coli and Salmonella LPS. J Med Microbiol 39 S1:331. (Abstract)
Di Padova, F.E., Gram, H., Barclay, G.R., Kleuser, B., Liehl, E. and Rietschel, E.T. New anticore LPS monoclonal antibodies with clinical potential. In: Endotoxin Research Series. Vol 2. Bacterial Endotoxin: Recognition and Effector Mechanisms, edited by Levin, J., Alving, C.R., Munford, R.S. and Stutz, P.L. Amsterdam: Elsevier.Science Publishers.B.V., 1993, p. 325-335.
Di Padova FE, Brade H, Barclay GR, Gram H, Poxton IR, Liehl E, Rietschel ET (1993): A chimeric monoclonal antibody (MAb) broadly cross-protective and binding to E.coli and Salmonella LPS. ICEA IV Abstracts & Programme 13. (Abstract)
Di Padova FE, Barclay GR, Brade H, Gram H, Poxton IR, Liehl E, Rietschel ET (1993): SDZ 219-800 a chimeric broadly cross-reactive and cross-neutralizing anti-core LPS antibody. Circ Shock ?? S1:47. (Abstract)
Dolan S, Erwin PJ, McCluggage G, Barclay GR, Halliday MI, Rowlands BJ (1993): Temporal relationship between anti-endotoxin antibodies and circulating TNF in an animal model of pancreatitis. ICEA IV Abstracts & Programme 45. (Abstract)
Fearon KCH, Goldie AS, Jackson R, Barclay GR, Ross JA, the Sepsis Intervention Group (1993): Selection of patients for trials. J Med Microbiol 39 S1:330. (Abstract)
Gardiner KR, Barclay GR, Halliday MI, Rowlands BJ (1993): Salivary antibodies to endotoxin are reduced in active inflammatory bowel disease. Falk Symp No 72:Abs 40. (Abstract)
Gardiner KR, Barclay GR, McCaigue MD, Erwin PJ, Halliday MI, Maxwell RJ, Rowlands BJ (1993): Increased host response to endotoxin in Crohn's disease. Irish J Med Sci 162:362. (Abstract)
Gardiner KR, Barclay GR, McMillan SA, Halliday MI, Rowlands BJ (1993): Differentiation of ulcerative colitis (UC) from Crohn's disease (CD). Gastroenterol 102:A626. (Abstract)
Goldie AS, Barclay GR, Jackson R, Fearon KCH, Ross JA, Ramsay G, the Sepsis Intervention Group (1993): Depletion of endogenous anti-endotoxin core antibodies in patients with severe abdominal sepsis. ICEA IV Abstracts & Programme 43. (Abstract)
Hodgson JC, Barclay GR, Hay LA, Moon GM, Poxton IR (1993): Prevention of endotoxaemia in colostrum-deprived, newborn lambs using human anti-LPS antiserum. Vet Immunol Immunopathol 35 S:82. (Abstract)
Neilly PJD, Erwin PJ, Anderson NH, Gardiner KR, Kirk SJ, Barclay GR, Rowlands BJ (1993): Endotoxin-core antibody concentrations reflect chronic endotoxin exposure in experimental colitis. ICEA IV Abstracts & Programme 45. (Abstract)
Oppenheim BA, Barclay GR, Morris J, Knox F, Barson A, Drucker DB, Crawley BA, Morris JA (1993): Antibodies to endotoxin core in sudden infant death syndrome. J Med Microbiol 39 S1:344. (Abstract)
Refsum SE, Halliday MI, Barclay GR, Campbell G, McCaigue MD, Erwin PJ, Rowlands BJ, Boston V (1993): Pentoxyfylline modulates cytokine responses in a sepsis model. ICEA IV Abstracts & Programme Abs O.27:18. (Abstract)
Barclay GR (1994): Serology of the core of Gram-negative bacterial endotoxin revealed by monoclonal antibodies: implications for immunotherapy. Transfus Med 4 S1:15. (Abstract)
Barclay GR (1994): Endogenous endotoxin-core antibody (EndoCAb) levels as markers of endotoxin exposure and prognostic indicators: a review. J Endotoxin Res 1 S1:8. (Abstract)
Clements WDB, Barclay GR, Erwin PJ, Halliday MI, Rowlands BJ (1994): Endogenous anticore glycolipid antibody production in obstructive jaundice. Int Care Med 20 S1:S11. (Abstract)
Di Padova FE, Barclay GR, Rietschel ET (1994): Anti-core LPS monoclonal antibodies: binding specificity and biological properties. Int Care Med 20 S1:S7. (Abstract)
Edmond DM, Barclay GR, Poxton IR (1994): TNF induction by B.fragilis lipopolysaccharide. J Endotoxin Res 1:S11. (Abstract)
Goldie AS, Barclay GR, Jackson RE, Fearon KCH, Ross JA, Lee A, Grant IS, the Scottish Sepsis Intervention Group (1994): Depletion of endogenous anti-endotoxin core antibodies in abdominal sepsis. Crit Care Clinics (Abstract)
Halliday MI, Soong CV, Barclay GR, Stephens S, Hood J, Rowlands BJ, Barros DS (1994): Colonic ischaemia and systemic inflammatory responses in elective abdominal aortic aneurysm repair (AAAR). J Endotoxin Res 1,S1:34. (Abstract)
Hamilton-Davies C, Barclay GR, Machin SJ, Webb AR (1994): Relationship between endotoxin immune status and outcome from cardiac valve surgery. Proceedings of the Association of Anaesthetists Winter Scientific Meeting Brigh (Abstract)
Di Padova, F.E., Gram, H., Barclay, G.R., Poxton, I.R., Liehl, E. and Rietschel, E.T. Monoclonal antibodies to endotoxin core as a new approach in endotoxemia therapy. In: , Marcel.Dekker.Inc.,New.York., 1995, p. 13-31.
Hamilton-Davies C, Barclay GR (1995): Relationship between endotoxin immune status and outcome following cardiac valve surgery. Brit J Anaesth 74:S34. (Abstract)
Hamilton-Davies C, Salmon J, Barclay GR, Behrens R (1995): The effect of monovalent typhoid vaccine on endotoxin immune status. Clin Intens Care 6:197. (Abstract)
Barclay GR (1996): Endotoxin-core antibody (EndoCAb) in perioperative gut ischaemia: a review of prospects for immunoprophylaxis of endotoxaemia. J Endotoxin Res 3:S29. (Abstract)
Hamilton-Davies C, Barclay GR, Cardigan R, Machin SJ, Webb AR (1996): Higher pre-operative levels of endogenous endotoxin immunity reduce peri-operative requirements for blood products in cardiac surgery. ?? (Abstract)
Welsh FKS, Ramsden CW, MacLennan K, Sheridan M, Windsor ACJ, Barclay GR, Guillou PJ, Reynolds JV (1996): Increased intestinal permeability and altered mucosal immunity in jaundiced patients. Br J Surg SRS Abstract
Ammori BJ, Leeder PG, King RFG, Barclay GR, Martin IG, Larvin M, McMahon MJ (1998): Early failure of intestinal barrier function and endotoxaemia in severe acute pancreatitis. (Abstract – presented at several meetings – three prizes/awards gained)
Halliday I, et al (Endotoxin Soc biennial meeting 1998 - find)
Hamilton-Davies C, Barclay R, Stidwell R, Rosser D, Singer M, Grocott M, Mythen M (1998): Sterile bred rats for studies involving endotoxin challenges have differing levels of endogenous immunity to endotoxin core. (Abstract: where?)
Paterson T, Innes J, McMillan L, Barclay R (1998): Recombinant antibodies. (Abstract: Scotblood 1998)
Bennettt-Guerrero E, Barclay GR, Weng P, Andres LA, Vela-Cantos F, Bodian CA (1999): Anti-endotoxin neutralizing activity of serum in patients prior to cardiac surgery: relationship to EndoCAb levels. (Abstract: where?)
Grocott M, Hamilton-Davies C, Barclay GR, Calvano S, Lowry S, Bennett-Guerrero E, Mythen MG (1999): Variation of endogenous endotoxin immunity between UK and US surgical patients. (Abstract: where?)